These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20826588)

  • 21. Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population.
    Frikke-Schmidt R
    Atherosclerosis; 2010 Feb; 208(2):305-16. PubMed ID: 19596329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetically elevated bilirubin and risk of ischaemic heart disease: three Mendelian randomization studies and a meta-analysis.
    Stender S; Frikke-Schmidt R; Nordestgaard BG; Grande P; Tybjaerg-Hansen A
    J Intern Med; 2013 Jan; 273(1):59-68. PubMed ID: 22805420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional promoter variant in zinc finger protein 202 predicts severe atherosclerosis and ischemic heart disease.
    Stene MC; Frikke-Schmidt R; Nordestgaard BG; Grande P; Schnohr P; Tybjaerg-Hansen A
    J Am Coll Cardiol; 2008 Jul; 52(5):369-77. PubMed ID: 18652945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in 5' promoter region of the APOE gene contributes to predicting ischemic heart disease (IHD) in the population at large: the Copenhagen City Heart Study.
    Stengård JH; Frikke-Schmidt R; Tybjaerg-Hansen A; Nordestgaard BG; Sing CF
    Ann Hum Genet; 2007 Nov; 71(Pt 6):762-71. PubMed ID: 17535270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.
    Do HQ; Nazih H; Luc G; Arveiler D; Ferrières J; Evans A; Amouyel P; Cambien F; Ducimetière P; Bard JM
    Metabolism; 2009 Mar; 58(3):283-9. PubMed ID: 19217440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation in ABCA1 predicted risk of ischemic heart disease in the Copenhagen City Heart Study Population.
    Frikke-Schmidt R; Nordestgaard BG; Schnohr P; Steffensen R; Tybjaerg-Hansen A
    J Am Coll Cardiol; 2005 Oct; 46(8):1516-20. PubMed ID: 16226177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study of the APOA1 XmnI and APOC3 SstI polymorphisms in the APOA1/C3/A4 gene cluster and risk of incident myocardial infarction in men.
    Liu S; Song Y; Hu FB; Niu T; Ma J; Gaziano M; Stampfer MJ
    Atherosclerosis; 2004 Nov; 177(1):119-26. PubMed ID: 15488874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonfasting glucose, ischemic heart disease, and myocardial infarction: a Mendelian randomization study.
    Benn M; Tybjaerg-Hansen A; McCarthy MI; Jensen GB; Grande P; Nordestgaard BG
    J Am Coll Cardiol; 2012 Jun; 59(25):2356-65. PubMed ID: 22698489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein A5 gene variants are associated with decreased adiponectin levels and increased arterial stiffness in subjects with low high-density lipoprotein-cholesterol levels.
    Kim M; Kim M; Yoo HJ; Bang YJ; Lee SH; Lee JH
    Clin Genet; 2018 Nov; 94(5):438-444. PubMed ID: 30132804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.
    Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Zuurman MW; van der Steege G; van Tol A; Dullaart RP;
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3382-8. PubMed ID: 16684835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study.
    Juul K; Tybjaerg-Hansen A; Marklund S; Heegaard NH; Steffensen R; Sillesen H; Jensen G; Nordestgaard BG
    Circulation; 2004 Jan; 109(1):59-65. PubMed ID: 14662715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High triglycerides/low high-density lipoprotein cholesterol, ischemic electrocardiogram changes, and risk of ischemic heart disease.
    Jeppesen J; Hein HO; Suadicani P; Gyntelberg F
    Am Heart J; 2003 Jan; 145(1):103-8. PubMed ID: 12514661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic variation in liver X receptor alpha and risk of ischemic vascular disease in the general population.
    Stender S; Frikke-Schmidt R; Anestis A; Kardassis D; Sethi AA; Nordestgaard BG; Tybjærg-Hansen A
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2990-6. PubMed ID: 21903943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic score based on high-risk genetic polymorphisms and early onset of ischemic heart disease in an Italian cohort of ischemic patients.
    Vecoli C; Adlerstein D; Shehi E; Bigazzi F; Sampietro T; Foffa I; Carpeggiani C; L'abbate A; Andreassi MG
    Thromb Res; 2014 May; 133(5):804-10. PubMed ID: 24656450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men.
    Clarke R; Emberson JR; Parish S; Palmer A; Shipley M; Linksted P; Sherliker P; Clark S; Armitage J; Fletcher A; Collins R
    Arch Intern Med; 2007 Jul; 167(13):1373-8. PubMed ID: 17620530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study.
    Suadicani P; Hein HO; Gyntelberg F
    Metab Syndr Relat Disord; 2010 Jun; 8(3):215-22. PubMed ID: 20156073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Marked high density lipoprotein deficiency due to apolipoprotein A-I Tomioka (codon 138 deletion).
    Wada M; Iso T; Asztalos BF; Takama N; Nakajima T; Seta Y; Kaneko K; Taniguchi Y; Kobayashi H; Nakajima K; Schaefer EJ; Kurabayashi M
    Atherosclerosis; 2009 Nov; 207(1):157-61. PubMed ID: 19473658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in APOA-I and ABCA1 in Norwegians with low levels of HDL cholesterol.
    Berge KE; Leren TP
    Clin Chim Acta; 2010 Dec; 411(23-24):2019-23. PubMed ID: 20800056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
    Yin RX; Wu DF; Miao L; Htet Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
    Biofactors; 2013; 39(3):315-25. PubMed ID: 23355348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.